Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
Completed treatment phase of pivotal EMERGE™ Phase 3 efficacy trial of STS101 as planned and remain on track to report […]
Number of shares and voting rights of Innate Pharma as at August 1, 2020
Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French […]
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the […]
Hermitage Offshore Services Ltd. (NYSE:PSV) and 28 subsidiaries file voluntary Chapter 11 petitions amid global oil slump and coronavirus pandemic
HAMILTON, Bermuda, Aug. 11, 2020 (GLOBE NEWSWIRE) — Hermitage Offshore Services Ltd. and 28 of its subsidiaries including all its […]
Overstock Announces Pricing of Upsized Public Offering of Common Stock
SALT LAKE CITY, Aug. 11, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) (“Overstock”) announces the pricing of its previously announced underwritten […]
TSX News -
Questerre reports second quarter 2020 results
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES […]
Plug Power Inc. Announces Pricing of Public Offering of Common Stock
LATHAM, N.Y., Aug. 11, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (“Plug Power”) (Nasdaq: PLUG), a leader in providing clean, […]
Maui Land & Pineapple Reports 2nd Quarter 2020 Results
KAPALUA RESORT, Hawaii, Aug. 11, 2020 (GLOBE NEWSWIRE) —Maui Land & Pineapple Company, Inc. (NYSE: MLP) reported a net loss […]
TSX News -
Melcor Developments announces second quarter results, declares quarterly dividend of $0.08 per share
EDMONTON, Alberta, Aug. 11, 2020 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (TSX: MRD), an Alberta-based real estate development and asset […]
RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico
The global Phase 2/3 study with opaganib is set to enroll up to 270 patients with severe COVID-19 across 40 clinical […]
